In-silico gene essentiality analysis of polyamine biosynthesis reveals APRT as a potential target in cancer

Jon Pey1,2, Edurne San José-Eneriz3,4, María Carmen Ochoa3,4

  • 1Bioinformatics Group, CEIT and TECNUN, University of Navarra, San Sebastian, 20018, Spain.

Scientific Reports
|November 1, 2017
PubMed

Insights

This study highlights the importance of polyamine metabolism in cancer. Analyzing essential genes, including Adenine Phosphoribosyltransferase (APRT), reveals new drug targets for cancer therapy.

Area of Science:

  • Metabolic Engineering
  • Cancer Biology
  • Computational Biology

Background:

  • Constraint-based modeling of genome-scale metabolic networks is a key tool for identifying cancer drug targets.
  • Polyamines are crucial for cancer cell proliferation but often overlooked in metabolic models.
  • Improving in-silico gene essentiality analyses requires focusing on metabolic routes supporting proliferation.

Purpose of the Study:

  • To analyze essential genes involved in polyamine biosynthesis for cancer drug target discovery.
  • To investigate the role of Adenine Phosphoribosyltransferase (APRT) in leukemia.
  • To enhance the accuracy of in-silico cancer metabolic models.

Main Methods:

  • Genome-scale metabolic network modeling.
  • In-silico gene essentiality analysis.
  • Gene silencing experiments in leukemia cell lines.

Main Results:

  • Confirmed the importance of known regulators like Adenosylmethionine Decarboxylase 1 (AMD1).
  • Identified novel enzymes critical for polyamine homeostasis.
  • Demonstrated that APRT gene silencing significantly impacts leukemia cell lines.

Conclusions:

  • Polyamines are vital targets for cancer therapy.
  • APRT is a potential therapeutic target in leukemia.
  • Revising metabolic models to include polyamine pathways can improve cancer drug discovery.

Related Concept Videos

Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
1.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
24
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
25
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.9K